ABOUT US

Throughout our 30+ year history, LICORbio has developed revolutionary fluorescence imaging technologies to address the growing needs of the global scientific community. Today LICORbio offers complete, integrated solutions for quantitative protein research, immunocytochemistry, virology, small animal imaging, and 2D and 3D cell culture imaging including z-stacks, morphology analysis, organoids, spheroids, and microphysiological systems.

The LICORbio Atlas™ Imaging System is the first in a new line of 3D cell culture imaging systems. Created for the demands of translational research, the LICORbio Atlas Imager delivers fast, precise 2D and 3D imaging without the need for stitching, intensity correction, or other time-consuming post-processing steps. It delivers reliable, quantifiable results in less time, so researchers can keep their focus where it belongs: on their next discovery.

The unique line-scanning technology of the LICORbio Atlas Imager enables whole-plate imaging in less than one minute, as well as higher-resolution, single-well scanning. It can also image through entire 3D samples in 0.01 mm increments to create stunning z-stacks and 2D projections of organoids, spheroids, and organ-on-a-chip systems. With over 30 imaging channels spanning UV to NIR, plus luminescence, brightfield, and epi-illumination, the LICORbio Atlas Imager simplifies workflows, eliminates inefficiencies, and captures deep spatial insights in a fraction of the time—and at a fraction of the cost—of competitive solutions.

With over 120,000 citations in peer-reviewed publications, industry-leading imaging systems, powerful analysis software, affordable reagents, and world-class scientific support, LICORbio empowers researchers around the world to answer difficult questions, make groundbreaking discoveries, and improve countless facets of human health. LICORbio is an ISO 9001:2015-certified company.

FEATURED ARTICLES

CONTACT INFORMATION

LICORbio

4647 Superior Street

Lincoln, NE 68504

UNITED STATES

Phone: 402-467-0800

Contact: Katie Schaepe